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Abstract
Background: Platelets are involved in the thromboses that are central to myocardial infarctions and ischemic strokes. Such
adverse cardiovascular events have day/night patterns with peaks in the morning (,9AM), potentially related to
endogenous circadian clock control of platelet activation. The objective was to test if the human endogenous circadian
system influences (1) platelet function and (2) platelet response to standardized behavioral stressors. We also aimed to
compare the magnitude of any effects on platelet function caused by the circadian system with that caused by varied
standardized behavioral stressors, including mental arithmetic, passive postural tilt and mild cycling exercise.
Methodology/Principal Findings: We studied 12 healthy adults (6 female) who lived in individual laboratory suites in dim
light for 240 h, with all behaviors scheduled on a 20-h recurring cycle to permit assessment of endogenous circadian
function independent from environmental and behavioral effects including the sleep/wake cycle. Circadian phase was
assessed from core body temperature. There were highly significant endogenous circadian rhythms in platelet surface
activated glycoprotein (GP) IIb-IIIa, GPIb and P-selectin (6–17% peak-trough amplitudes; p#0.01). These circadian peaks
occurred at a circadian phase corresponding to 8–9AM. Platelet count, ATP release, aggregability, and plasma epinephrine
also had significant circadian rhythms but with later peaks (corresponding to 3–8PM). The circadian effects on the platelet
activation markers were always larger than that of any of the three behavioral stressors.
Conclusions/Significance: These data demonstrate robust effects of the endogenous circadian system on platelet
activation in humans—independent of the sleep/wake cycle, other behavioral influences and the environment. The ,9AM
timing of the circadian peaks of the three platelet surface markers, including platelet surface activated GPIIb-IIIa, the final
common pathway of platelet aggregation, suggests that endogenous circadian influences on platelet function could
contribute to the morning peak in adverse cardiovascular events as seen in many epidemiological studies.
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Introduction
The risks for major adverse cardiovascular events, including
myocardial infarction, stroke, and sudden cardiac death, have
daily patterns with peaks in the morning (,6AM-noon) [1,2,3].
These peaks may be related to the morning peak in platelet
function [4], which plays a critical role in the formation of an
occlusive thrombus [5]. Behavioral stressors such as postural
changes upon awakening are known to activate platelets [4,6].
However, it is also possible that the endogenous circadian timing
system—which generates circadian rhythms (,24-h) in many
physiological variables [7] —contributes to this day/night pattern.
In the current study, by using a forced desynchrony protocol
(Figure 1), we tested the hypotheses that: (1) there is an
endogenous circadian rhythm in platelet function in humans and
(2) there is an endogenous circadian rhythm in the sensitivity of
platelet function changes in response to standardized behavioral
stressors (mental stress, postural tilt and exercise). We also aimed to
compare the magnitude of any effects on platelet function caused
by the circadian system with the magnitude of any effects caused
by varied standardized behaviors, including mental stress, passive
postural tilt and mild exercise. We used both flow cytometry and
whole blood aggregability (WBA) testing to assess platelet function.
Methods
Other physiological aspects of this study have been previously
published [7,8,9]. The protocol in the current study was an
arduous forced desynchrony protocol, comprised of subjects living
in the laboratory for 13 days in dim light. Given the intensive
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24549nature of the study, we took the opportunity to prospectively test a
number of independent hypotheses by making comprehensive
measurements across the circadian cycle of platelet function
(current manuscript), exercise reactivity [7], passive head up tilt
table testing [8], and blood pressure based on combined data from
this protocol and two additional protocols [9].
Subjects
Twelve (6 male; 6 female) healthy volunteers (mean6SD
[range]; 25.865.7y [20–42y]; BMI: 23.663.2 kg/m
2 [19.9–
29.6 kg/m
2]) completed a 13-day ‘inpatient’ protocol in the
Clinical and Translational Research Center at Brigham and
Women’s Hospital. All subjects gave written informed consent, the
studies were approved by Partners Human Research Committee
and the studies conformed to the principles expressed in the
Declaration of Helsinki. Prior to enrollment, participants under-
went extensive screening including medical history, physical and
psychological examination, psychological questionnaires, electro-
cardiogram, and biochemical analysis of blood and urine to
confirm that subjects were healthy. To ensure a stable rhythmicity
of the circadian system at the time of admission to the laboratory,
subjects maintained a regular sleep/wake cycle of 8 h sleep per
night for 2–3 weeks immediately prior to admission as verified by
sleep/wake diaries, call-in times to a time-stamped voice recorder
and wrist actigraphy (Actiwatch; Minimitter, Bend, OR). Subjects
reported no shift work for three years or crossing more than one
time zone for three months prior to study. To minimize training
and detraining effects while in the study, subjects maintained an
exercise level equivalent to a 30-min brisk walk per day for the 2–3
weeks immediately prior to admission. Toxicology screens upon
admission confirmed that subjects were free of any drugs,
including caffeine, alcohol and nicotine.
Protocol
Subjects spent 13 days and nights in a private laboratory room in
constant dim light to avoid resetting the phase of the circadian
system (0 lux during scheduled sleep and ,1.8 lux during scheduled
wakefulness), at constant temperature (,75uF) and free of time cues
(Figure 1). The environment and many behaviors including
physical and mental stresses, sleep, waking and postural changes,
can all affect platelet function and were precisely controlled or
scheduled. Following two baseline days and nights (16 h of
scheduled wakefulness and 8 h of scheduled sleep), subjects
completed a forced desynchrony protocol designed to desynchro-
nize the behavioral and circadian cycles, consisting of twelve 20-h
‘days’ (13 h and 20 min of scheduled wakefulness, 6 h 40 min of
scheduled sleep; maintaining a 1:2 sleep:wake ratio) in dim light.
Desynchrony between the behavioral and circadian cycles occurs
because the 20-h rest/activity cycle in dim light is outside the range
of entrainment of the human circadian system, so the circadian
system runs free at its inherent rate of close to 24 h [10]. Thus, the
sleep and wake episodes as well as all scheduled behaviors were
uniformly distributed across the circadian cycle twice (i.e., 2 ‘‘beat
cycles’’). Behavioral test batteries were performed each day, lasted
,210 min and included three standardized stressors performed in
the following order: (i) a mental stressor (10-min serial addition test);
(ii) a postural stressor (passive 15-min 60u head-up tilt on tilt table
[Model T7605, Metron Medical Australia Pty Ltd, Carrum Downs,
Victoria, Australia]); and (iii) an exercise stressor (15-min cycling on
an ergometerat 60%maximum heartratewithfixed resistance load
cycling at 70 rpm [Cybex Semirecumbent Cycle Ergometer,
DivisionofLumex,Ronkonkoma,NY]).Eachstressorwaspreceded
by a separate 20–25 min baseline period, and followed by a 20-min
recovery period. Before each test battery, subjects had been supine
for 6 h 40 min during the sleep periods and subsequently, upon
lightson,remained ina semi-recumbentposture (upperbody at45u)
for 2 h 55 min. Subjects were provided with a urinal or bedpan as
needed during that time. During each test session, subjects
maintained the same body posture: semi-recumbent during mental
stress session, supine during the tilt session excepting the scheduled
head up tilt, and seated on the cycle ergometer; were asked to limit
any movement excepting the scheduled cycling; and not to talk
except in response to structured questions. In between the three test
sessions within each test battery there were two 20-min breaks
during which subjects were gently slid from bed to tilt table and
calmly walked ,2 m from the tilt table to the cycle ergometer,
respectively.
Circadian Phase Assessment
Each measurement was assigned a circadian phase (0u–359u)
based on non-orthogonal spectral analyses of continuous core
body temperature recorded throughout the forced desynchrony
protocol, with the fitted core body temperature minimum set to 0u,
as previously published [10]. To facilitate translation of circadian
phase to clock time, we report ‘‘corresponding clock time’’, defined
as the group-average clock time at which a circadian phase would
have occurred under normal entrained conditions i.e., with
subjects sleeping at their habitual times during the night, and
awake during the day (in these subjects, 0u occurred at ,4:30 AM;
60u occurred at ,8:30 AM, etc.).
Blood Sampling
Blood was sampled at 20-minute intervals across the test
batteries via a 12-foot intravenous catheter with heparin infusion
Figure 1. Protocol. Rasterplot, including two baseline days, twelve 20-
h cycles, and discharge day of an example subject with a habitual
bedtime of midnight. Blue bars, baseline and discharge wake episodes
in normal room light (,90 lux); solid back bars, scheduled sleep (0 lux);
gray bars, wake episodes in dim light (,1.8 lux); red bars, timing of the
test batteries; dotted line illustrates the circadian core body temper-
ature minimum throughout the protocol, with an average circadian
period of 24.09h in these subjects. Each test battery consisted of a
mental, tilt, and exercise stress (S) test, each preceded and followed by
a baseline (B) and recovery (R) episode. The timing of the blood draws is
indicated as red filled circles.
doi:10.1371/journal.pone.0024549.g001
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section of each of the three stress tests (mental stress test, tilt table
test and exercise test; see Figure 1 for details on timing of blood
samples). For WBA, blood samples were assayed from each of the
12 test batteries (each of the twelve 20-h ‘days’) for all subjects. For
flow cytometry assays (including platelet count) blood samples
were assayed from the 6 test batteries during the second half of the
forced desynchrony protocol, thus spanning a full circadian cycle,
for eleven subjects (technical difficulties precluded analysis of data
in the other subject). As opposed to 9 blood samples per test
battery being used for all other variables, for ATP release, only the
first blood sample during each of the 12 test batteries (mental
baseline) was assayed for ten subjects (technical difficulties
precluded analysis of data in the other two subjects).
Flow Cytometry
Blood samples were assayed by whole blood flow cytometric
detection of platelet surface GPIb alpha, P-selectin, and activated
GPIIb-IIIa (reported by the binding of monoclonal antibody
PAC1) [11]. Monoclonal antibody PAC-1 recognizes only the
conformationally activated form of GPIIb-IIIa [12]. The specific
commercially available monoclonal antibodies used were fluores-
cein isothiocyanate (FITC)-conjugated PAC-1 (Becton Dickinson),
phycoerythrin (PE)-conjugated anti-P-selectin (DAKO-Cytoma-
tion), and PE-Cy5 conjugated anti-GPIb (BD-Pharmingen).
Samples were analyzed in a FACSCalibur (Becton Dickinson)
flow cytometer calibrated daily with Spherotech RCP-30-5
calibration beads to assure consistent fluorescence measurements.
Platelet surface activated GPIIb-IIIa was expressed as percent
positive platelets; platelet surface P-selectin and GPIb were
expressed as mean fluorescent intensity (MFI). Forward light
scatter in the flow cytometer was used as an approximate estimate
of platelet size (with increased forward light scatter signifying
increased size of platelets) [13].
Whole blood platelet aggregability (WBA)
Whole blood samples (1 mL) were collected in sodium citrate
tubes. Each blood sample was diluted 1:1 [450 mL whole blood
and 450 mL of physiological saline (NaCl)] at 37uC. Platelet
aggregability was assessed in duplicate by stimulation with 5 mg/
mL collagen by dual channel whole blood/optical lumi aggreg-
ometer (560VS, Chrono-Log Corporation, Havertown, PA) and
analyzed with Chrono-Log software (Aggro/Link for Windows).
Platelet aggregability was quantified by the area under the curve of
the impedance signal across 10 min immediately following
stimulation with collagen and reported in Ohm*sec. For quality
control, data were excluded if duplicates differed by more than
12.5% from the mean (excluding 18% of data), resulting in a CV
of 7%. ATP release from platelets was assessed by the addition of
100 ml of Chrono-lume solution (0.16 mg/ml luciferin and
17,600 U/ml d-luciferase). All WBA measurements were com-
pleted within 20 min of the blood draw.
Statistical Analysis
Based on pre-hoc criteria to eliminate likely ‘spurious outliers’,
values more than 3 standard deviations from the mean within each
subject across all wake periods were excluded from the analysis.
Thereafter, the effects of the circadian cycle and the behavioral
stressors of the test batteries were assessed by cosinor analyses
using mixed model ANOVA’s for each variable including a
fundamental circadian component (,24-h), a harmonic compo-
nent (,12-h), and the 9 test conditions (baseline, exercise and
recovery for mental stress, postural stress, and exercise stress test).
Tukey’s range tests were performed to assess changes across the
test battery. All statistical analysis was performed by JMP (SAS
Institute) and significance was set at p,0.05.
Results
The average circadian period estimated from core body
temperature measurements was 24.0960.22h [mean6SEM;
range: 23.8–24.6h]. There were no significant interactions
between circadian phase and time into the behavioral test battery
(mental stress, postural tilt and exercise); so all reported statistics
are based on mixed model ANOVA’s across circadian phase
without interaction.
Effect of Circadian Cycle (independent of changes in
behavior and environment)
For the group, there were highly significant endogenous circadian
rhythms in platelet surface activated GPIIb-IIIa, platelet surface
GPIb, platelet surface P-selectin, and platelet size (p always #0.01),
with circadian peaks corresponding to the epidemiologically
identified vulnerable period of ,6:30-9AM, (Figure 2 and
Table 1). The peak-to-trough circadian amplitudes ranged from
6-17% for the platelet surface antigens and 2% for estimated platelet
size. Platelet count, ATP release, platelet whole blood aggregability
and plasma epinephrine also had significant circadian rhythms but
with later peaks (3-8PM). Although the circadian peak in plasma
epinephrine occurred after the vulnerable morning period, the fastest
rate of increase occurred during the vulnerable period (Figure 2).
Effect of Mental Stress, Postural Tilt and Exercise
(independent of circadian phase)
WBA, platelet count, and plasma epinephrine significantly varied
across the standardized test battery (all P,0.0001; Figure 3, right
panels), due to an increase during exposure to the three behavioral
stressors usually with incomplete recovery between subsequent
stressors. Mental stress generally had the smallest effects (6% for
WBA, n.s. for platelet count and plasma epinephrine), while the
effects of tilt and of exercise were larger (averaging 11% for WBA,
9% for platelet count, and 91% plasma epinephrine). We could not
test for an effect of the test battery on platelet ATP release because
this was assessed only during resting baseline conditions. Platelet
surface activated GPIIb-IIIa, P-selectin, GPIb, and platelet size
increased gradually across the test battery (all P,0.05; Figure 3,
left panels), increasing from mental baseline to mental recovery,
for all four flow cytometry measures (all P,0.05), but without
consistent changes across the tilt table test or the exercise test.
Comparison of Effects of Circadian Cycle and Behavioral
Stressors
The magnitudes of the circadian effects (peak-to-trough
difference; Table 1) on the platelet activation markers were
always larger than the effects of any of the three separate stressors:
GPIIb-IIIa (circadian: 17% vs. behavioral stressors: max 10%), P-
selectin (6% vs. max 3%), GPIb (9% vs. max 4%), and estimated
platelet size (2% vs. max 1%). The magnitudes of the effects of the
circadian system on platelet count (6%) and plasma epinephrine
(68%) were comparable to the magnitudes of the effects of the
three stressors (platelet count: 1–9%; epinephrine: 10–94%). Only
for platelet aggregability was the circadian influence smaller than
that of the stressors (4% vs. 6–11%).
Discussion
Our results reveal a potentially important influence of the
circadian system on platelet function in humans. Many previous
Body Clock Regulates Platelet Function
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function [4], but ours is the first to determined the influence on
platelet function of the circadian system separate from the
influences of the changes in behavior and environment that
normally occur across the day and night, including changes in
sleep/wake state, supine/upright posture, rest/activity, fasting/
feeding, and the light/dark cycle [7].
Potential clinical relevance
A better understanding of the relative importance of circadian
rhythms and behaviors on platelet function is important especially
for the increasing number of shift workers, travelers across time
zones, and people with sleep disorders in whom influences of the
circadian system are uncoupled from those of their behaviors. Shift
workers, including even permanent night workers, typically
experience chronic and/or recurrent misalignment between the
circadian system and the sleep/wake cycle [14,15]. Also sleep
disorders, especially circadian rhythm sleep disorders, are
associated with chronic and/or recurrent circadian misalignment
[16]. In jet lag, the misalignment is transient, although the number
of days required for reentrainment may depend on the organ
systems involved [17]. The absence of statistical interaction
between circadian phase and the behavioral stressors suggests
that the effect of the circadian system and behavioral stressors on
platelet function are additive. The magnitude of the circadian
effect was always larger than that of any of the three separate
stressors for all platelet surface markers of platelet activation.
Given that shift workers are at increased risk for cardiovascular
events [18] this larger effect of the circadian system as compared to
behavioral stressors on platelet activation may warrant future
studies to determine whether antiplatelet therapy in shift workers
can be further optimized by basing the timing of therapy on their
internal circadian phase rather than on their behavioral sleep/
wake cycle. The three measured surface markers of platelet
activation peaked at an endogenous circadian phase correspond-
ing to 8–9AM, consistent with our hypothesis of the presence of an
endogenous circadian rhythm in platelet function peaking around
the vulnerable time for major adverse cardiovascular events (6AM-
noon [1,2,3]). This is of likely clinical importance as these factors
represent measures of the final common pathway of platelet
aggregation (GPIIb-IIIa) [12]; adhesion of activated platelets to
monocytes and neutrophils (P-selectin) [19]; and adhesion of
activated platelets to subendothelial collagen in the blood vessel
wall (GPIb) [20]. Indeed, FDA-approved drugs (abciximab,
integrilin and tirofiban) that block GPIIb-IIIa are of benefit as
antithrombotic therapy in acute coronary syndromes [21], and in
animal models, antagonism of platelet surface P-selectin [22] and
platelet surface GPIb [23] has antithrombotic benefit. The later
circadian peaks in aggregability (representing platelet reactivity),
platelet count and ATP release suggest that these may not be as
relevant to the day/night pattern of increased risk for throm-
boembolistic events in the morning as the measures of platelet size
and platelet surface activated antigens (GPIIb-IIIa, P-selectin,
surface GPIb), which represent in vivo circulating activated
platelets.
Potential mechanisms involved in circadian variation in
platelet function
The circadian rhythms in circulating platelet function could be
caused by circadian rhythms in three general mechanisms: (i)
humoral factors, including hormones (e.g., epinephrine, norepi-
nephrine, melatonin and cortisol), endothelial-derived factors (e.g.,
nitric oxide, prostacyclin), platelet-derived factors (e.g., ATP), and
other blood-borne substances (e.g., fibrinogen, factor VII, 5-
hydroxytrypamine, vasopressin); (ii) release or sequestering of
platelets by the spleen, liver, lungs, and/or bone marrow, which is
Table 1. Endogenous circadian rhythms in platelet function from cosinor analyses.
Variable P-value circadian P-value harmonic
Timing peak
(degrees)
Timing peak
(clocktime)
Peak-to-trough
amplitude
Peak-to-trough
amplitude (% of
mean)
GPIIb-IIIa 0.012 n.s. 70u ,9AM 5.1% pos 17%
P-selectin 0.0065 n.s. 70u ,9AM 0.22 MFI 6%
GPIb 0.0008 n.s. 50u ,8AM 19.8 MFI 9%
Estimated platelet size ,0.0001 n.s. 30u ,6:30AM 2.0 A.U. 2%
Aggregability 0.033 n.s. 230u ,8PM 3.6V*min 4%
ATP release 0.023 n.s. 160u ,3PM 0.08nM 16%
Platelet count 0.0099 n.s. 160u ,3PM 0.12610
5/mL6 %
Epinephrine ,0.0001 0.0087 210u ,6:30PM 17 pg/mL 68%
doi:10.1371/journal.pone.0024549.t001
Figure 2. Independent influence of circadian cycle on platelet function. Cosinor models of circadian rhythms in platelet function. Cosinor
and other statistical analysis were performed on the 360u data sets, whereas data are double plotted (2 identical circadian cycles) to aid visualization
of rhythmicity (the second circadian cycle data were not used for analyses). Each of the platelet surface markers of platelet activation (activated GPIIb-
IIIa, P-selectin, and GPIb) and platelet size had significant endogenous circadian rhythms with circadian peaks corresponding to the vulnerable time
of 6AM-noon (indicated by the orange bars). Platelet count, ATP release, WBA and plasma epinephrine also had significant circadian rhythms but with
peaks later in the circadian cycle (3–8PM). The cosine models (black lines) and 95% confidence intervals (gray areas) are based on mixed model
analyses and use precise circadian phase data. To show that these models adequately fit the actual data, we also plot average data grouped into 60
circadian degree windows with SEM error bars (averaged data are not double plotted). Bottom x-axes, circadian phase with 0u indicating the timing
of the core body temperature minimum (average ,4:30AM in these subjects); top x-axes, corresponding average clock time in these subjects; left y-
axes, absolute values; right y-axes, percentage of each individual’s mean across the protocol; P values, significance of circadian effect from cosinor
analyses.
doi:10.1371/journal.pone.0024549.g002
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24549Figure 3. Independent influence of behavioral stressors on platelet function. WBA, platelet count, and plasma epinephrine were increased
by each of the three stressors, with a (partial) recovery during recovery. In contrast, while the platelet surface markers showed a gradual increase
across the approximately 3-h test battery, there was no consistent increase and recovery caused by the three stressors. Mental, mental stress test; tilt,
passive head up tilt table test; exercise, cycle exercise test; B, baseline; S, stress test; R, recovery; x-axes, minutes from first blood sample within test
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intrinsic circadian oscillations within the anucleate platelets [25].
Indeed, although mechanisms for intrinsic circadian oscillations in
platelets are unknown, circadian rhythms that are independent of
transcription-translation feedback loops have recently been
demonstrated in human red blood cells that are also anucleate
and involve redox cycles of peroxiredoxins [26]. Humoral factors
that express large-amplitude endogenous circadian rhythms and
that could drive the endogenous circadian rhythm in platelet
function include cortisol, epinephrine, norepinephrine, and
melatonin that have a concurrent peak (cortisol [7,27]), rapid rise
(epinephrine [Figure 2] and norepinephrine [7]), or rapid fall
(melatonin [28,29]) at the time of the circadian peak in the platelet
surface markers of platelet activation. Future studies are required
to investigate the relative influence of these circadian hormones on
platelet function and to determine whether or not other humoral
factors show relevant endogenous circadian rhythms and phases,
independent of the behavioral sleep/wake and fasting/feeding
cycle.
Differences in timing of the endogenous circadian peaks
between the platelet surface markers and WBA may be explained
in part by the different circadian timing between platelet count
and platelet surface markers, because platelet surface markers (as
measured here on individual platelets) are not influenced by
changes in platelet count, while WBA is increased with increasing
platelet count. Alternatively, there may be a ‘ceiling effect’ in the
aggregometry assay since platelets that are already partially
activated in vivo at 9AM (as assessed by platelet surface activation
markers) may be refractory to further ex vivo activation by collagen
during WBA [30].
The endogenous circadian rhythms in platelet activity and
platelet aggregability are consistent with recent data showing a
direct effect of core clock genes, such as Bmal1, Clock and Per2,o n
the activity of key factors in hemostasis, such as von Willebrand
factor and megakaryocytes [31,32,33]. Furthermore, these recent
data demonstrate that disruption of the positive limb of the
primary transcription-translation feedback loop driving circadian
oscillations (BMAL1/CLOCK) leads to a prothrombotic pheno-
type while disruption of the negative limb (e.g., Per2) leads to a
hemorrhagic phenotype.
Potential mechanisms involved in effects of behavioral
stressors on platelet function
Tilt and exercise, but not mental stress, caused an increase in
platelet count simultaneously with large increases in epinephrine
(Figure 3). The increase in catecholamines may explain—at least
in part—the observed changes in platelet count, because
catecholamines can stimulate immediate release of platelets from
the spleen [24]. The increase in platelet count may subsequently
help explain the simultaneous increase in platelet aggregability in
response to these behavioral stressors. On the other hand, the
platelet surface makers did not consistently increase specifically
during the tilt and exercise tests, nor decrease during the recovery
phases following these stressors. The absence of a clear effect of
postural stress (i.e., passive head-up tilt) on platelet surface markers
of platelet activation and the presence of a clear increase in WBA,
platelet count, and epinephrine in response to the head-up tilt is
consistent with a previous study that examined the effect on
platelets of the transition from lying to standing [34]. Also the
absence of a clear effect of exercise on surface markers of platelet
activation is consistent with a previous study by our group in
which exercise failed to cause consistent changes in platelet
activation in physically active subjects [6]. Interestingly, in that
same study, we showed that exercise by sedentary subjects did
result in significant platelet activation [6].
Therapeutic considerations
There is clear evidence that the presently measured markers of
platelet activation are clinically relevant. FDA-approved drugs
(abciximab, eptifibatide and tirofiban) that block GPIIb-IIIa (the
platelet receptor that we specifically measured by flow cytometry
and the receptor upon which whole blood aggregometry is
specifically dependent [35]) are of benefit as antithrombotic
therapy in acute coronary syndromes [21]. In animal models,
antagonism of platelet surface P-selectin [22] and platelet surface
GPIb [23] has antithrombotic benefit. A better understanding of
the relative importance of circadian rhythms and behaviors on
platelet function may help reveal new therapeutic targets for
cardiac patients. Ultimately, chronotherapy could be designed to
specifically target pharmacological or behavioral interventions to
those time windows of greatest risk for cardiovascular events.
Rather than the current clinical practice of attempting to maintain
therapeutic levels of antiplatelet drugs throughout each day and
night or base medication timing on presumed patient convenience,
it may be therapeutically beneficial for antiplatelet agents to
specifically target the circadian phases of greatest platelet
aggregability to reduce thrombotic complications, while minimiz-
ing hemorrhagic complications during periods of reduced platelet
aggregation [36].
Limitations and Strengths
Limitations of this initial study of the endogenous circadian
rhythmicity in platelet function include: inclusion of healthy
controls rather than individuals at risk for cardiovascular events;
small group size; and no assessment of fibrinolytic activity. We also
note that the blood sampling technique incorporating a 12-foot i.v.
line with heparin infusion is non-standard in flow cytometry
studies, and conceivably could have affected some platelet function
measures—although any such effects are likely to be consistent
across the protocol and would not explain the observed changes
across the circadian cycle. Circadian analysis of a subset of the
WBA and platelet count data (i.e., data at rest immediately before
exercise and data during exercise) has previously been published
[7] and showed a ,12-h (circadian harmonic) rhythmicity for
WBA and no rhythmicity for platelet count. The increase in
statistical power by inclusion of ,4.5 times more data in the
current analysis may help explain why we now find significant
circadian rhythmicity for both WBA (P=0.03) and platelet count
(P=0.01). In addition, we cannot exclude the possibility that the
effect of the circadian system and behavioral state interact,
although such putative interaction did not reach statistical
significance in the current study. The strengths of the study
include: the forced desynchrony protocol allowing the systematic
assessment of effects of the human endogenous circadian system
on platelet function—independent of changes in environment and
behavior; the highly controlled laboratory environment; an
battery; left y-axes, absolute values; right y-axes, data expressed as a percentage of each individual’s mean values across the forced desynchrony
protocol; error bars, SEM; P-values, significance for effect of time across full stress test battery (9 time points); *, significance for change between
consecutive samples (from baseline to stress test and from stress test to recovery). Note platelet ATP release is not shown (see above text).
doi:10.1371/journal.pone.0024549.g003
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over 13 consecutive days; and the comprehensive assessment of
platelet function, including various estimates of the in vivo state of
platelet activation (activated platelet surface GPIIb-IIIa, platelet
surface P-selectin, platelet surface GPIb), in vitro platelet reactivity
(WBA and ATP release), and platelet count. These results
represent a valuable ‘reference’ data set in healthy young people,
critical for comparison with vulnerable populations.
Conclusion
The present data show a robust influence of the endogenous
circadian system on platelet function independent of the sleep/
wake cycle. If these data collected in healthy individuals can be
extrapolated to more vulnerable populations, this would suggest
that the endogenous circadian rhythms in platelet surface activated
GPIIb-IIIa, platelet surface P-selectin, and platelet surface GPIb
may play a causal role in the morning peak in adverse
cardiovascular events. Thus, future circadian studies are required
to investigate the responsible circadian signals underlying the
circadian rhythms in platelet activity and whether there are
differences in the timing and magnitude of these circadian effects
in vulnerable populations, such as subjects who are older,
sedentary, or obese and patients with coronary artery disease,
prior myocardial infarction, or heart failure.
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